Every list on this site runs through the same six checks. A provider climbs when its own pages answer them clearly and drops when they dodge.
The six checks
1. Physician oversight. Who actually decides on a prescription, and whether that physician holds a Florida license. If a site only mentions a vague “care team,” it loses ground here.
2. Labs first, then monitoring. Blood work should come before any hormone is started, with follow-up labs on a stated schedule once treatment is under way. Accepting recent labs from your own doctor earns credit.
3. Treatment range. How many options the physician has to work with: injections, creams, pellets or oral medicines, and care for men, women or both.
4. Published pricing and contract terms. A price printed on the website beats one revealed on a call. We also note memberships, minimum commitments, auto-renewal and what lab work adds to the bill.
5. FDA-status disclosure. Compounded hormones and hormone pellets are not FDA-approved. A provider that says so in plain words ranks above one that skips it or hides it behind “natural” language.
6. Access in Miami. Whether you can be seen in person, by telehealth or both, and where. A Coral Gables office does little for someone in Aventura unless video visits are on offer.
Men and women ranked apart
TRT and menopause care call for different labs, different medicines and often different specialists. Where the needs split, so do our lists. Pages that cover both make clear which picks are for women.
Where the facts come from
Every provider fact is taken from that provider’s current website and nowhere else. We use no customer reviews, no rating scores, no sales calls and no third-party directories. Every page shows the date its facts were checked.
Monthly rechecks
We go back to each provider’s pages once a month. When a price, a treatment or a policy has moved, the listing and its position move with it.
Researched and written by the Hormone Therapy Miami editorial team in Miami. Updated November 2026. How we rank providers · editorial policy.